Evidence map›Paper›PMID 21119659›Full record

ArticleBritish journal of cancer2010

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials.

V Jenkins, D Farewell, L Batt, T Maughan, L Branston, C Langridge, L Parlour, V Farewell, L Fallowfield

Abstract read
In one paragraph

Article in British journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Decision aids for people considering taking part in clinical trials.The Cochrane database of systematic reviews · 2015
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014
    Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Text Classification of Cancer Clinical Trial Eligibility Criteria.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

V JenkinsCancer Research Psychosocial Oncology Group, Brighton & Sussex Medical School, University of Sussex, Sussex, UK. val@sussex.ac.uk
D Farewell
L Batt
T Maughan
L Branston
C Langridge
L Parlour
V Farewell
L Fallowfield

Funding

Cancer Research UKMedical Research Council G0601724Medical Research Council G0902108Medical Research Council MC_U105261167
6 · The paper itself

Abstract

backgroundbarriers to randomised clinical trial (RCT) recruitment include failure to identify eligible patients, reluctance of staff to approach them and attitudes of some health-care professionals and patients. As part of a larger UK prospective study examining the communication and involvement in RCTs of 22 multidisciplinary teams in Wales, we also assessed the attitudes of patients they treat towards trials.

methodsout of 1146 patients attending outpatient departments who were approached, 1146 (93%) completed the seven-item Attitudes to Randomised Trials Questionnaire (ARTQ), probing their general attitudes towards medical research and likely participation in a hypothetical two-arm RCT.

resultsrandomisation initially deterred many patients from endorsing a willingness to participate. However, if information about the trial logic, voluntary nature and rights to withdraw were provided, together with further treatment details, 83% (886 out of 1066) would potentially participate. Other variables associated with a positive inclination towards participation included previous trial experience (P<0.01), male gender (P<0.01) and younger age, with patients > or =70 years less likely to consider trial entry (P<0.01).

conclusionthe majority of patients were receptive to RCT participation. Many of those initially disinclined because of randomisation would consider joining if given further details that form part of standard GCP consent guidelines. These data show the importance and need for clear communication and information to encourage RCT participation. Evidence-based training courses are available to assist with this.

Indexed as

AttitudeAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMultivariate AnalysisNeoplasmsProspective StudiesRandomized Controlled Trials as TopicSurveys and Questionnaires

Identifiers

PMID21119659
PMCPMC3008615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.